DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 171 filers reported holding DEPOMED INC in Q4 2014. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $81,000 | -2.4% | 12,128 | -3.4% | 0.00% | 0.0% |
Q1 2018 | $83,000 | -46.5% | 12,557 | -34.7% | 0.00% | 0.0% |
Q4 2017 | $155,000 | -6.6% | 19,231 | +126.7% | 0.00% | 0.0% |
Q2 2016 | $166,000 | +59.6% | 8,482 | +13.7% | 0.00% | 0.0% |
Q1 2016 | $104,000 | +4.0% | 7,458 | +35.1% | 0.00% | 0.0% |
Q4 2015 | $100,000 | -27.5% | 5,521 | -24.9% | 0.00% | 0.0% |
Q3 2015 | $138,000 | +181.6% | 7,347 | +222.2% | 0.00% | – |
Q2 2015 | $49,000 | +22.5% | 2,280 | +28.1% | 0.00% | – |
Q1 2015 | $40,000 | +42.9% | 1,780 | +1.9% | 0.00% | – |
Q4 2014 | $28,000 | -9.7% | 1,747 | -15.0% | 0.00% | – |
Q3 2014 | $31,000 | +3.3% | 2,055 | -6.0% | 0.00% | – |
Q2 2014 | $30,000 | -6.2% | 2,186 | 0.0% | 0.00% | – |
Q1 2014 | $32,000 | +45.5% | 2,186 | +3.2% | 0.00% | – |
Q4 2013 | $22,000 | -59.3% | 2,119 | -70.5% | 0.00% | – |
Q3 2013 | $54,000 | +145.5% | 7,189 | +86.9% | 0.00% | – |
Q2 2013 | $22,000 | – | 3,846 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 1,876,195 | $42,045,000 | 9.16% |
Senvest Management, LLC | 3,331,531 | $74,660,000 | 4.62% |
Krensavage Asset Management, LLC | 343,546 | $7,699,000 | 3.51% |
PERKINS CAPITAL MANAGEMENT INC | 97,950 | $2,195,000 | 1.84% |
HAYS ADVISORY LLC | 580,069 | $12,999,000 | 1.68% |
ARBOR CAPITAL MANAGEMENT LLC | 572,200 | $12,823,000 | 1.54% |
Broadfin Capital, LLC | 705,204 | $15,804,000 | 1.23% |
EMERALD MUTUAL FUND ADVISERS TRUST | 556,311 | $13,969,000 | 1.14% |
Pier Capital, LLC | 330,682 | $7,411,000 | 1.12% |
TURNER INVESTMENTS LLC | 259,357 | $5,812,000 | 1.04% |